Free Trial
NYSEAMERICAN:AMS

American Shared Hospital Services (AMS) Stock Price, News & Analysis

American Shared Hospital Services logo
$2.39 +0.01 (+0.42%)
As of 05/28/2025 04:10 PM Eastern

About American Shared Hospital Services Stock (NYSEAMERICAN:AMS)

Key Stats

Today's Range
$2.36
$2.40
50-Day Range
$2.35
$3.00
52-Week Range
$2.33
$4.60
Volume
10,681 shs
Average Volume
43,836 shs
Market Capitalization
$15.34 million
P/E Ratio
3.98
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Receive AMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Shared Hospital Services and its competitors with MarketBeat's FREE daily newsletter.

AMS Stock News Headlines

Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
See More Headlines

AMS Stock Analysis - Frequently Asked Questions

American Shared Hospital Services' stock was trading at $2.72 at the beginning of the year. Since then, AMS shares have decreased by 12.1% and is now trading at $2.39.
View the best growth stocks for 2025 here
.

American Shared Hospital Services (NYSEAMERICAN:AMS) issued its quarterly earnings data on Monday, May, 11th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $4.57 million for the quarter. American Shared Hospital Services had a trailing twelve-month return on equity of 4.01% and a net margin of 15.74%.

Shares of AMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that American Shared Hospital Services investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), AbbVie (ABBV), Meta Platforms (META), NVIDIA (NVDA), Pfizer (PFE) and Verizon Communications (VZ).

Company Calendar

Last Earnings
5/11/2020
Today
5/28/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NYSEAMERICAN:AMS
Previous Symbol
NYSEMKT:AMS
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
3.98
Forward P/E Ratio
4.60
P/E Growth
N/A
Net Income
$610 thousand
Pretax Margin
14.79%

Debt

Sales & Book Value

Annual Sales
$21.33 million
Cash Flow
$0.80 per share
Price / Cash Flow
2.97
Book Value
$4.17 per share
Price / Book
0.57

Miscellaneous

Free Float
4,943,000
Market Cap
$15.34 million
Optionable
Not Optionable
Beta
0.66
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSEAMERICAN:AMS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners